≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

Endpoint Browser

C3_FEMALE_GENITAL_NAS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C57
  • Hospital discharge: ICD-9 — 184
  • Hospital discharge: ICD-8 — 183
  • Cause of death: ICD-10 — C57
  • Cause of death: ICD-9 — 184
  • Cause of death: ICD-8 — 183
  • Cause of death: excluded ICD-8 — 1830
  • Cancer registry: Topography ICD-O-3 — C57
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

912

4. Check minimum number of events

None

912

5. Include endpoints

None

912

6. Filter based on genotype QC (FinnGen only)

912

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 912 912 -
Unadjusted period prevalence (%) 0.31 0.31 -
Median age at first event (years) 67.18 67.18 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
401
Matched controls
4010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
710.2
323.0
280
13
128
Kela drug reimbursment
Cancers of female genital organs
+∞
323.0
296
*
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
263.6
223
*
A04AA01
ATC
ondansetron; systemic, rectal
107.0
219.6
231
50
A03FA01
ATC
metoclopramide; systemic, rectal
41.1
213.2
314
323
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
210.5
183
*
JAL30
NOMESCO Finland
Omentectomy
985.0
190.6
172
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
183.9
162
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
147.2
132
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1955.9
145.1
132
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
140.0
126
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
70.0
138.3
156
36
R18
ICD-10 Finland
Ascites
222.4
136.1
134
9
B01AB10
ATC
tinzaparin; parenteral
31.4
132.6
183
104
JN4BD
NOMESCO Finland
Extensive body CT
32.1
123.3
168
88
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
115.3
105
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
115.3
105
*
Z51.5
ICD-10 Finland
Palliative care
68.3
109.4
124
26
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
30.4
106.4
146
74
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
1271.7
104.1
97
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
101.5
93
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
100.3
92
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
24.9
99.1
145
89
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
91.2
84
*
L02BG04
ATC
letrozole; oral
531.8
88.8
85
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
977.4
83.7
79
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
32.7
80.6
107
44
A04AA55
ATC
palonosetron, combinations; systemic
886.5
77.0
73
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
75.4
70
*
JEA00
NOMESCO Finland
Appendectomy
17.4
73.1
121
97
TPH07
NOMESCO Finland
Cathetrisation of artery
12.3
70.3
139
166
N02AA05
ATC
oxycodone; systemic
9.6
69.3
163
268
JAL00
NOMESCO Finland
Biopsy of peritoneum
207.5
68.4
69
*
LCD00
NOMESCO Finland
Hysterectomy
12.6
65.5
126
140
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
61.0
57
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
21.7
59.4
89
52
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
78.6
59.3
66
10
ZX120
NOMESCO Finland
Intravenous
12.2
57.9
112
123
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
56.6
53
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
56.6
53
*
C574, 8461, 3
ICD-O-3
NA
+∞
56.6
53
*
WW500
NOMESCO Finland
Blood transfusion
35.6
55.1
71
24
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.5
53.7
222
737
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
8.0
53.6
137
243
JN4AD
NOMESCO Finland
Body CT examination
18.3
53.5
85
58
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.2
53.4
74
33
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
53.3
50
*
115
Kela drug reimbursment
Breast cancer
+∞
53.3
50
*
A04AA02
ATC
granisetron; systemic, transdermal
198.4
51.2
52
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
51.1
48
*
B01AB05
ATC
enoxaparin; parenteral
5.1
50.3
230
834
JAH01
NOMESCO Finland
Laparoscopy
14.2
50.2
89
79
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
46.8
44
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
502.0
46.2
45
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
19.3
45.9
71
44
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
19.0
45.0
70
44
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
43.5
41
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
240.0
42.8
43
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
42.4
40
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
160.0
41.6
43
*
WX402
NOMESCO Finland
General anaesthesia
5.9
41.3
134
314
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
40.3
38
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.3
40.2
221
895
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
39.2
37
*
L03AA02
ATC
filgrastim; parenteral
402.7
37.7
37
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
37.1
35
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
58.4
36.2
42
8
130
Kela drug reimbursment
Malignant tumour
+∞
36.0
34
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
21.6
36.0
53
28
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
32.8
31
*
C579, 8461, 3
ICD-O-3
NA
+∞
32.8
31
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
25.8
31.7
44
19
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
31.7
30
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
31.7
30
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
50.8
31.2
37
8
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
30.6
29
*
Z31.5
ICD-10 Finland
Genetic counselling
12.1
29.6
55
52
X77
ICPC
Malignant neopl genital female other
+∞
29.5
28
*
TJA10
NOMESCO Finland
Laparocentesis
+∞
29.5
28
*
3009
Kela drug reimbursment
Niraparib
+∞
29.5
28
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
30.7
29.5
39
14
WF049
NOMESCO Finland
Radiotherapy of metastasis
313.5
29.2
29
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.1
29.1
139
463
1510
Kela drug reimbursment
Niraparib
+∞
28.5
27
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
28.5
27
*
JAH00
NOMESCO Finland
Laparotomy
17.5
27.9
44
28
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
16.2
27.7
45
31
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
27.4
26
*
1XC07
NOMESCO Finland
NA
+∞
27.4
26
*
HA1AA
NOMESCO Finland
X-ray mammography
7.9
26.9
64
94
L02BA01
ATC
tamoxifen; oral
+∞
26.3
25
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.7
25.0
60
89
JFB46
NOMESCO Finland
Resection of sigmoid colon
23.8
24.8
35
16
D70.82
ICD-10 Finland
Drug-induced neutropenia
132.9
23.9
25
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.1
23.3
47
52
HAC20
NOMESCO Finland
Total mastectomy
243.3
22.9
23
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
22.3
126
467
L01XK02
ATC
niraparib; oral
+∞
22.1
21
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
85.0
21.9
24
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.0
21.1
30
14
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
21.0
20
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
21.0
20
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
21.0
20
*
A79
ICPC
Malignancy NOS
+∞
21.0
20
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
21.0
20
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
21.0
20
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
21.5
20.7
30
15
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.7
20.6
40
41
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
20.0
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
77.2
19.9
22
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
30.8
19.9
26
9
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.0
19.7
86
255
JFB00
NOMESCO Finland
Partial resection of small intestine
33.2
19.5
25
8
WX306
NOMESCO Finland
Lumbar epidural anesthesy
6.6
19.2
51
87
C50.99
ICD-10 Finland
Breast, unspecified
+∞
18.9
18
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
18.9
18
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
18.9
18
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
198.9
18.7
19
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
11.5
18.3
34
32
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
34.7
18.2
23
7
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
17.8
17
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.8
17.3
40
56
WZC30
NOMESCO Finland
Teaching
4.4
17.2
66
172
K56.7
ICD-10 Finland
Ileus, unspecified
18.4
17.2
26
15
J94.8
ICD-10 Finland
Other specified pleural conditions
27.0
17.1
23
9
8441/3-C57.0
ICD-O-3
Serous carcinoma, NOS, of fallopian tube
+∞
16.8
16
*
1511
Kela drug reimbursment
Olaparib
+∞
16.8
16
*
389
Kela drug reimbursment
Olaparib
+∞
16.8
16
*
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
+∞
16.8
16
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
16.8
16
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
16.6
60
147
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.4
16.2
87
301
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
16.2
80
261
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
15.7
15
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
14.5
15.7
26
19
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.5
15.1
55
136
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
22.1
14.8
21
10
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
14.7
14
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
155.4
14.6
15
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.3
14.5
79
275
JN3AD
NOMESCO Finland
Abdominal CT examination
4.1
14.5
58
157
JFB30
NOMESCO Finland
Right hemicolectomy
28.4
14.4
19
7
LCA06
NOMESCO Finland
Biopsy of endometrium
3.0
14.4
95
380
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
44.2
14.2
17
*
JN4CD
NOMESCO Finland
Very extensive body CT
13.4
14.1
24
19
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.6
13
*
ZXC40
NOMESCO Finland
Use of ultrasound
33.2
12.7
16
5
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
12.6
12
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
12.6
12
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
12.6
12
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
12.6
12
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
12.6
12
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
134.0
12.5
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
12.2
204
1302
A02BC02
ATC
pantoprazole; systemic
2.3
12.0
300
2277
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
17.1
11.8
18
11
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
19.6
11.7
17
9
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
11.6
11.7
21
19
R50.9
ICD-10 Finland
Fever, unspecified
3.2
11.6
65
230
A04AA03
ATC
tropisetron; systemic
+∞
11.5
11
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
11.5
11
*
8380/3-C57.0
ICD-O-3
Endometrioid adenocarcinoma, NOS, of fallopian tube
+∞
11.5
11
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
11.5
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
123.4
11.5
12
*
JFF10
NOMESCO Finland
Loop enterostomy
123.4
11.5
12
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
17.7
11.3
17
10
SPAT1109
SPAT
Analgesia with portable analgesic pump
28.9
10.8
14
5
B03XA02
ATC
darbepoetin alfa; parenteral
13.4
10.7
18
14
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
10.6
114
590
L02BG03
ATC
anastrozole; oral
112.8
10.5
11
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
+∞
10.5
10
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
+∞
10.5
10
*
GAE03
NOMESCO Finland
Suture of chest wall
+∞
10.5
10
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
10.5
10
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
10.5
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.5
10
*
8140/3-C57.0
ICD-O-3
Adenocarcinoma, NOS, of fallopian tube
+∞
10.5
10
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
10.5
10
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
10.5
10
*
JFF23
NOMESCO Finland
Transversostomy
33.5
10.4
13
*
Z93.3
ICD-10 Finland
Colostomy status
33.5
10.4
13
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
19.4
10.3
15
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
10.3
66
255
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
9.8
49
160
WF004
NOMESCO Finland
Palliative radiotherapy
56.4
9.7
11
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
102.3
9.5
10
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
102.3
9.5
10
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
102.3
9.5
10
*
L01XK01
ATC
olaparib; oral
+∞
9.4
9
*
8140/3-C57.9
ICD-O-3
Adenocarcinoma, NOS, of female genital tract, NOS
+∞
9.4
9
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
9.4
9
*
L01XX46
ATC
[U] olaparib; oral
+∞
9.4
9
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
9.4
9
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
9.4
9
*
8000/3-C57.9
ICD-O-3
Neoplasm, malignant of female genital tract, NOS
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
2.8
9.1
369
3226
WF002
NOMESCO Finland
Radical radiotherapy
37.6
9.1
11
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
19.1
9.0
13
7
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
24.7
9.0
12
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.8
8.9
17
18
R4190
NOMESCO Finland
Nutritional therapy
6.7
8.6
21
33
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
28.2
8.5
11
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
28.2
8.5
11
*
WX892
NOMESCO Finland
Monitored bed care
3.4
8.5
41
131
A04AD12
ATC
aprepitant; systemic
91.9
8.4
9
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
91.9
8.4
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.4
168
1103
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
8.4
8
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
8.4
8
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
8.4
8
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
8.4
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
8.4
8
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
+∞
8.4
8
*
JFF30
NOMESCO Finland
Other colostomy
+∞
8.4
8
*
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
8.4
8
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
8.4
8
*
WX704
NOMESCO Finland
Intubation
3.4
8.2
39
123
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.4
7.9
13
10
D25
ICPC
Abdominal distension
7.2
7.9
18
26
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.7
7.8
33
95
JFA80
NOMESCO Finland
Suture of colon
45.9
7.7
9
*
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
45.9
7.7
9
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
18.8
7.6
11
6
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.0
7.6
29
76
KBV10
NOMESCO Finland
Removal of stent from ureter
25.6
7.6
10
*
S18
ICPC
Laceration/cut
1.8
7.6
182
1256
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
81.5
7.4
8
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
81.5
7.4
8
*
ZX100
NOMESCO Finland
Oral
13.7
7.4
12
9
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
7.3
7
*
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
7.3
7
*
L01XX54
ATC
[U] niraparib; oral
+∞
7.3
7
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
7.3
7
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
7.3
7
*
LAF17
NOMESCO Finland
Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
X81
ICPC
Genital neopl female other/unspecif
+∞
7.3
7
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
7.3
7
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.6
7.3
31
90
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
16.1
7.3
11
7
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
7.2
37
124
M54.5
ICD-10 Finland
Low back pain
0.5
7.2
57
1043
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
7.2
61
277
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
30.6
7.2
9
*
WX725
NOMESCO Finland
Noninvasive ventilation
3.7
6.8
28
79
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
40.7
6.8
8
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
40.7
6.8
8
*
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
40.7
6.8
8
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.9
6.7
9
*
Z51.88
ICD-10 Finland
Other specified medical care
5.7
6.7
18
33
ZXC96
NOMESCO Finland
Robot assisted procedure
12.5
6.6
11
9
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.5
6.5
18
34
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
70.9
6.4
7
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
70.9
6.4
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
70.9
6.4
7
*
R4110
NOMESCO Finland
Physiotherapy
1.9
6.3
113
699
A06AH03
ATC
naloxegol; oral
18.4
6.3
9
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
6.3
41
162
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour                  
+∞
6.3
6
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
6.3
6
*
C54.14
ICD-10 Finland
Serous papillary carcinoma of the endometrium
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
JFB43
NOMESCO Finland
Left hemicolectomy
27.1
6.2
8
*
WX600
NOMESCO Finland
Single shot through catheter
27.1
6.2
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
6.1
182
1319
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
6.1
24
66
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
10.2
6.1
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4281824)
385
60
110.31
307.65
1.4
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
375
191
32.65
307.65
1.7
1.5
pmol/l
812.5
67.3
19.09
362
186
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
732
424
83.41
307.65
20.2
1.6
u/ml
250.6
23.0
5.63
725
403
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
505
474
22.63
307.65
2.0
1.4
ug/l
7.0
3.2
0.84
304
355
(4035726)
379
223
28.37
307.65
1.5
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
230
178
16.94
250.15
1.8
1.8
u/ml
71.7
133.1
0.28
185
146
(3012095) Magnesium [Moles/volume] in Serum or Plasma
425
1064
6.61
174.78
6.7
2.2
mmol/l
0.8
0.8
11.00
414
965
(3033799) Differential panel - Peritoneal fluid
86
11
86.22
162.37
1.3
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
82
12
74.99
151.70
1.3
2.7
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
81
13
68.28
147.60
1.3
3.2
e6/l
7983.7
211268.0
—
29
5
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
157
159
11.72
141.67
1.6
2.4
g/l
3.8
3.4
1.63
157
153
(3024561) Albumin [Mass/volume] in Serum or Plasma
712
3353
6.12
128.55
6.7
3.4
g/l
31.9
35.8
46.36
702
3057
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
699
3250
5.93
127.96
5.0
3.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
85
31
30.13
126.81
1.5
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
545
2100
4.96
126.19
3.0
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
479
1693
4.85
123.43
5.0
3.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
304
752
5.56
121.20
6.1
5.5
mmol/l
0.2
1.4
6.57
276
584
(3000991) Gas panel - Venous blood
248
514
6.25
120.00
6.4
6.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
303
757
5.50
119.24
6.1
5.5
kpa
5.2
5.1
0.83
297
720
(3027801) Oxygen [Partial pressure] in Arterial blood
302
757
5.47
118.30
6.1
5.5
kpa
16.7
11.8
27.45
296
717
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
145
174
9.72
114.95
1.6
2.1
%
91.9
93.4
0.25
145
158
(3013650) Neutrophils [#/volume] in Blood by Automated count
774
4176
6.64
111.11
29.1
6.5
e9/l
3.6
4.1
10.12
660
3523
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
730
3761
5.72
110.75
11.3
3.4
umol/l
9.1
10.7
2.13
719
3482
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
443
1629
4.34
104.66
2.9
2.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
75
52
15.63
84.44
1.3
1.4
g/l
40.1
28.2
6.08
70
45
(3002173) Hemoglobin [Mass/volume] in Arterial blood
233
620
4.70
82.22
6.5
6.0
g/l
111.5
119.1
8.89
227
595
(3042936) Bacteria identified in Isolate by Culture
287
929
4.05
77.50
1.9
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
562
2819
3.59
77.08
2.6
1.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
66
45
15.73
74.85
1.4
1.4
e6/l
19962.1
166009.0
0.44
33
22
(3023199) Leukocytes [#/volume] in Pleural fluid
69
53
14.00
73.21
1.4
1.4
e6/l
1240.0
1616.7
0.40
46
38
(3012441) Differential panel - Pleural fluid
62
41
16.15
71.41
1.5
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
410
1771
3.39
70.03
20.8
4.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
574
3035
3.40
69.83
7.2
8.4
inr
1.1
1.2
3.19
166
857
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
61
44
14.79
67.00
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
60
43
14.87
66.12
1.4
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
78
88
9.60
64.02
1.7
1.9
u/ml
40.2
53.9
0.18
72
81
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
109
184
6.59
63.23
1.5
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
525
2744
3.15
62.93
7.5
3.6
e6/l
112.9
126.7
0.12
344
1841
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
220
681
3.94
61.98
2.3
2.0
u/l
31.7
34.6
0.41
190
565
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
106
182
6.46
60.41
2.4
2.7
u/ml
0.3
0.4
0.53
44
115
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
43
19
23.70
59.26
1.7
1.1
u/ml
49.8
18.4
2.08
43
19
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
624
3698
3.18
58.10
6.3
4.6
mmol/l
1.2
1.2
29.98
596
3237
(3002582) Erythrocytes [#/volume] in Urine
450
2250
2.97
56.74
3.5
3.0
e6/l
69.1
58.5
0.14
326
1668
(3015377) Calcium [Moles/volume] in Serum or Plasma
514
2764
2.97
56.59
5.8
2.1
mmol/l
2.4
2.4
2.82
488
2269
(36304419) Bacteria [Presence] in Urine
419
2043
2.94
54.90
3.3
2.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
184
560
3.86
52.49
1.8
1.9
g/l
0.2
0.2
1.00
163
519
(3030467) Casts [#/volume] in Urine by Automated count
420
2103
2.85
51.58
3.5
3.0
e6/l
0.9
0.5
0.75
299
1549
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
286
1182
3.07
49.74
3.2
2.6
e6/l
3.7
4.6
0.56
134
592
(3002256) Pathology report gross observation
183
585
3.66
48.31
1.2
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
136
352
4.37
48.27
6.5
5.4
mmol/l
24.6
25.2
1.24
136
352
(3020630) Protein [Mass/volume] in Serum or Plasma
196
656
3.53
48.23
6.7
1.4
g/l
63.6
67.1
7.38
190
581
(3003694) ABO and Rh group [Type] in Blood
351
1681
2.77
45.82
1.4
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
634
4114
2.78
44.06
6.7
5.0
mmol/l
1.2
1.2
34.04
570
3468
(3026008) Bacteria identified in Urine by Culture
513
3013
2.61
43.58
3.5
3.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
441
2436
2.57
42.25
3.3
3.1
ph
7.4
7.4
0.53
55
396
(3021601) Nitrite [Presence] in Urine by Test strip
625
4081
2.69
41.92
12.9
5.6
estimate
0.0
0.0
0.00
126
677
(3009261) Glucose [Presence] in Urine by Test strip
628
4111
2.69
41.89
8.8
4.2
estimate
0.0
0.0
1.08
135
680
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
807
6062
3.88
41.44
12.7
5.3
u/l
91.5
76.4
7.03
789
5547
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
288
1310
2.75
40.79
3.1
2.5
e6/l
1.9
1.8
0.03
138
721
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
198
758
3.06
38.37
2.5
2.0
umol/l
7.8
5.8
0.61
168
643
(3016502) Oxygen saturation in Arterial blood
182
673
3.13
37.39
6.9
5.8
%
97.0
95.2
2.28
177
645
(3013826) Glucose [Moles/volume] in Serum or Plasma
657
4537
2.60
36.84
6.0
3.8
mmol/l
6.7
6.7
0.30
639
4191
(42870588) Differential panel, method unspecified - Blood
438
2545
2.39
35.88
6.5
5.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
405
2281
2.40
35.54
7.5
2.5
u/l
48.8
31.0
0.49
397
2160
(3011397) Hemoglobin [Presence] in Urine by Test strip
373
2028
2.42
35.42
8.4
4.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
738
5447
2.86
35.21
6.9
5.1
e6/l
652.8
4133.2
1.80
15
67
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
25
11
23.34
34.20
1.8
2.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
60
106
5.99
32.92
1.3
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
31
24
13.34
32.42
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
627
7681
0.41
31.22
5.0
6.3
mmol/mol
39.5
40.0
0.97
570
7038
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
192
827
2.67
29.21
1.6
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
513
3372
2.19
29.17
17.6
8.4
e9/l
0.0
0.0
1.72
396
2690
(3008152) Bicarbonate [Moles/volume] in Arterial blood
126
433
3.22
28.92
7.8
6.1
mmol/l
25.1
24.9
0.19
120
396
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
191
832
2.64
28.34
1.6
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
527
3526
2.17
28.32
7.1
5.9
%
8.8
8.5
1.02
508
3228
(3035350) Ketones [Presence] in Urine by Test strip
580
4039
2.20
28.00
9.2
4.2
estimate
0.0
0.0
0.00
123
683
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
102
317
3.50
27.46
8.7
8.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
136
504
3.00
27.36
1.6
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
511
3419
2.12
26.95
6.9
5.7
%
0.6
0.7
4.62
494
3116
(3019060) Gas panel - Arterial blood
124
441
3.10
26.78
5.2
4.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
528
3594
2.11
26.39
7.0
5.8
%
24.3
28.8
13.73
508
3277
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
308
1708
2.21
26.31
1.7
1.7
mg/l
2.4
1.2
6.23
275
1310
(3006504) Eosinophils/100 leukocytes in Blood
519
3517
2.10
26.16
6.9
5.7
%
2.1
2.9
8.79
502
3208
(3000850) Epithelial cells [#/volume] in Urine
293
1603
2.22
25.79
2.6
2.5
e6/l
9.2
7.8
0.53
257
1379
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
714
8200
0.40
25.43
4.4
5.5
mmol/l
2.9
2.8
2.40
624
7436
(3001604) Monocytes [#/volume] in Blood
545
3785
2.09
25.42
7.1
5.5
e9/l
0.6
0.6
0.73
453
3173
(3006315) Basophils [#/volume] in Blood
545
3804
2.08
24.84
7.1
5.5
e9/l
0.0
0.0
2.01
451
3192
(3037467) Urinalysis macro (dipstick) panel - Urine
722
5649
2.33
24.00
10.0
4.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
548
3879
2.03
23.46
7.2
5.5
e9/l
1.6
1.9
16.63
466
3327
(40768793) Breast Pathology biopsy report
46
88
5.45
23.17
1.2
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
553
3943
2.02
22.99
7.3
5.7
e9/l
0.1
0.2
12.58
467
3374
(3018010) Neutrophils/100 leukocytes in Blood
513
3566
2.00
22.89
6.8
5.6
%
60.0
56.7
5.29
494
3261
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
694
8013
0.44
22.62
3.8
4.9
mmol/l
5.0
4.8
2.73
617
7298
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
686
7948
0.45
22.25
3.6
4.8
mmol/l
1.6
1.6
0.74
608
7193
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
286
1633
2.09
21.97
3.2
2.3
mmol/l
2.5
2.5
12.93
265
1406
(3026782) Osmolality of Urine
264
1474
2.11
21.44
2.8
2.7
mosm/kgh2o
493.8
506.8
0.52
226
1234
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
387
2491
1.96
21.04
3.8
2.2
u/l
57.6
59.1
0.23
368
2245
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
273
1560
2.07
20.74
3.2
3.9
ng/l
61.1
265.8
2.82
218
1243
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
105
396
2.87
20.26
1.6
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
24
27
9.10
19.49
1.5
1.2
ug/l
32.5
15.4
0.97
24
27
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
218
1171
2.13
19.34
1.7
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
184
930
2.23
19.00
2.2
2.4
%
21.6
22.0
0.13
158
781
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
112
453
2.68
18.88
1.6
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
69
214
3.41
18.54
3.0
3.5
—
—
—
0
0
(3044889) 12 lead EKG panel
711
5744
2.08
18.52
4.5
3.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
62
184
3.54
17.82
1.9
2.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
159
780
2.26
17.56
1.6
1.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
74
250
3.13
17.30
4.8
3.4
mmol/l
1.6
1.4
0.31
74
243
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
61
5.58
17.23
1.6
1.8
u/l
2.7
3536.2
0.50
19
26
(3003458) Phosphate [Moles/volume] in Serum or Plasma
176
910
2.16
17.03
3.7
3.8
mmol/l
1.0
1.0
0.36
167
818
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
273
1676
1.90
16.23
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
78
284
2.91
16.00
5.4
4.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
667
7662
0.52
15.97
3.3
4.3
mmol/l
1.3
1.3
1.10
589
6846
(3023383) Lactate [Moles/volume] in Pleural fluid
15
14
10.88
13.78
1.3
1.1
mmol/l
4.6
1.8
2.58
15
14
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
146
759
2.10
13.75
3.7
3.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
721
8026
0.51
13.72
4.5
5.1
mmol/l
5.9
5.9
0.76
649
7214
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
1171
0.31
12.93
3.9
5.0
%
31.7
34.2
0.93
27
736
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
79
325
2.57
12.80
4.7
3.2
mmol/l
24.7
24.5
0.29
74
288
(3002032) Base excess in Venous blood by calculation
125
666
2.02
10.91
4.0
3.0
mmol/l
1.9
2.2
0.45
107
553
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
696
7732
0.58
10.39
5.4
5.5
mu/l
2.0
2.1
0.32
629
6993
(3027945) Reticulocytes/100 erythrocytes in Blood
140
789
1.91
10.37
2.1
2.3
%
2.0
1.9
0.45
133
685
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
145
3.06
10.12
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
145
3.06
10.12
1.3
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
851
7801
2.36
9.95
26.6
12.3
mg/l
40.0
20.2
45.99
812
5993
(3051651) Icteric interference index of Serum or Plasma
16
27
6.01
9.14
2.4
4.5
—
—
—
0
0
(3012544) pH of Venous blood
124
702
1.89
9.02
4.0
3.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
26
68
3.91
9.01
4.3
1.4
u/ml
7.0
1940.0
0.51
26
68
(40761536) Microorganisms panel - Urine sediment
111
607
1.94
8.96
13.5
4.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
53
214
2.57
8.95
6.0
5.4
mmol/l
1.2
1.2
0.10
47
190
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
10
10.10
8.65
1.3
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
161
2431
0.59
8.39
1.5
1.6
mmol/l
1.4
1.3
0.74
141
2027
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
39
140
2.87
8.26
1.4
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
17
7.14
8.01
1.2
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
37
132
2.88
7.93
1.1
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
595
6747
0.66
7.77
4.6
4.6
pmol/l
15.2
15.0
1.28
543
6085
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
297
3854
0.66
7.75
2.0
2.3
nmol/l
78.2
81.9
1.36
258
3372
(3051611) Lipemic interference index of Serum or Plasma
26
76
3.49
7.71
2.3
3.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
159
1037
1.65
7.02
10.6
26.9
inr
1.1
1.3
—
8
147
(3029937) Albumin [Presence] in Urine by Test strip
284
2128
1.49
6.75
9.5
4.7
estimate
0.0
0.0
0.00
124
687
(3019225) pH of Specimen
41
875
0.44
6.32
3.8
3.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
265
1982
1.48
6.28
1.8
2.3
mg/l
2.9
3.0
0.44
219
1667
(1761868) Lipid panel - Serum or Plasma
173
2405
0.65
5.88
2.5
3.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
102
620
1.73
5.84
3.3
3.7
%
1.4
0.6
1.53
54
103
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
102
1598
0.59
5.84
1.2
1.3
iu/ml
28.0
41.3
0.54
28
511
(3049717) Cytology report of Urine Cyto stain
44
201
2.25
5.75
2.4
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
748
6830
1.53
5.66
38.2
14.2
%
36.1
38.5
17.65
555
4446
(1616796) Gas panel - Central venous blood
31
125
2.53
5.33
2.9
3.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
39
3.89
5.28
2.4
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
102
1556
0.61
5.19
1.1
1.3
u/ml
11.7
14.4
0.22
32
575
(40760892) CBC W Ordered Manual Differential panel - Blood
211
1563
1.46
5.13
6.5
4.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
96
596
1.68
5.10
1.9
2.5
e9/l
66.5
71.7
0.46
44
448
(3014051) Protein [Presence] in Urine by Test strip
46
226
2.09
5.05
3.2
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
34
148
2.35
4.99
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
61
334
1.89
4.95
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
88
541
1.69
4.85
1.3
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
8
7
11.51
4.79
2.4
3.0
%
56.9
58.6
—
8
7
(3045414) Leukocytes [Presence] in Urine
68
400
1.76
4.40
2.9
2.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
12
7.56
4.36
3.2
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
89
2.63
4.33
1.3
1.4
—
—
—
0
0
(3013512) EKG study
199
2555
0.72
4.12
3.6
4.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
42
221
1.94
3.88
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
14
46
3.08
3.54
1.4
1.5
nmol/l
0.1
0.3
—
8
36
(44790048)
16
57
2.84
3.53
1.2
1.4
—
—
—
0
0
(44790047)
16
57
2.84
3.53
1.2
1.4
—
—
—
0
0
(44806118)
16
57
2.84
3.53
1.2
1.4
—
—
—
0
0
(44790049)
16
57
2.84
3.53
1.2
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
80
524
1.58
3.48
5.3
2.8
pmol/l
4.4
4.5
0.19
73
445
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
91
620
1.52
3.33
6.7
2.3
ml/min/173m2
57.5
65.0
1.51
48
253
(3025130) Human papilloma virus identified in Specimen
22
96
2.32
3.28
1.6
1.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
24
110
2.21
3.21
4.3
1.9
%
59.5
63.4
0.31
24
110
(3019309) Folate [Moles/volume] in Red Blood Cells
129
1709
0.71
3.13
1.7
1.7
nmol/l
1132.9
1194.3
0.36
97
1237
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
516
4633
1.26
3.01
4.7
2.9
u/l
57.7
41.8
2.51
479
4199
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
307
0.38
2.96
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
87
605
1.48
2.91
1.3
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
30
3.36
2.91
2.3
2.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
83
578
1.48
2.77
3.7
3.9
%
0.0
1.0
0.49
37
91
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
27
139
1.97
2.72
7.9
3.4
%
60.0
57.8
0.33
27
139
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
60
2.53
2.71
1.8
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
233
2779
0.78
2.65
3.7
3.8
mg/mmol
22.0
7.8
2.80
145
1547
(3037121) Protein [Mass/volume] in Urine
41
244
1.71
2.64
8.7
2.2
g/l
0.1
0.4
2.21
30
60
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
35
588
0.58
2.63
1.2
1.2
iu/ml
99.9
134.3
0.36
13
227
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
15
4.69
2.60
1.4
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
26
469
0.54
2.52
1.4
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
16
4.40
2.48
1.3
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
116
2.01
2.47
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
389
0.50
2.47
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
89
2.16
2.46
1.1
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
45
2.69
2.45
2.0
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
98
725
1.39
2.39
5.8
3.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
83
598
1.43
2.35
3.7
3.8
%
0.3
0.0
1.67
41
96
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
297
2566
1.23
2.27
2.6
2.9
ng/l
1750.4
1200.3
0.49
271
2165
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
229
2692
0.80
2.23
2.0
2.1
u/l
125.4
170.2
1.69
220
2520
(3011648) Oxygen content in Venous blood
13
54
2.43
2.20
1.1
1.6
%
9.1
10.7
0.70
13
54
(3019832) Treponema pallidum Ab [Presence] in Serum
11
253
0.43
2.17
1.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
101
2.00
2.16
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
26
144
1.83
2.16
4.0
2.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
37
579
0.62
2.13
1.4
1.5
%
1.3
1.4
0.21
27
487
(3003181) Sodium [Moles/volume] in Urine
27
153
1.79
2.10
1.4
1.4
mmol/l
56.6
63.8
0.41
18
123
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
786
7541
1.31
2.08
36.7
11.5
ml/min/173m2
76.2
75.5
0.49
675
5955
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
20
3.52
2.06
1.9
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
287
0.48
2.05
1.3
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
329
3699
0.83
2.03
2.1
2.0
pmol/l
92.4
99.6
2.47
186
1648
(40767503) Oxygen content in Capillary blood by calculation
25
140
1.81
2.02
1.8
2.2
%
15.1
16.2
0.62
14
68
(3009508) Creatinine [Moles/volume] in Urine
231
2686
0.81
2.00
3.2
3.0
mmol/l
5.9
6.1
0.36
200
2223
(40768443) Skin Pathology biopsy report
52
356
1.49
1.95
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
29
173
1.70
1.91
3.6
3.5
ph
7.4
7.4
0.24
24
136
(3013290) Carbon dioxide [Partial pressure] in Blood
24
136
1.79
1.88
4.0
4.0
kpa
4.7
5.1
1.33
24
136
(3012501) Base excess in Blood by calculation
24
136
1.79
1.88
4.0
3.9
mmol/l
3.4
2.9
0.35
15
97
(3008898) HLA-B27 [Presence]
11
236
0.46
1.85
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
137
1.77
1.84
8.3
3.1
e9/l
4.9
4.1
0.30
24
137
(3027315) Oxygen [Partial pressure] in Blood
24
137
1.77
1.84
4.0
3.9
kpa
9.5
8.4
2.20
24
137
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
145
1.74
1.83
1.1
1.2
miu/ml
255.3
230.0
—
7
58
(3028626) Oxygen [Partial pressure] in Capillary blood
25
145
1.74
1.83
2.0
2.6
kpa
8.1
8.0
0.14
25
135
(3012516) Albumin [Mass/volume] in Urine
228
2632
0.82
1.81
3.1
3.1
mg/l
647.0
213.9
0.56
143
1451
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
35
2.59
1.80
1.6
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
47
2.36
1.78
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
124
1.79
1.77
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
23
132
1.76
1.75
2.1
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
54
2.24
1.74
1.1
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
854
8327
1.40
1.73
39.7
14.7
mmol/l
138.8
139.8
27.46
848
8080
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
163
1.68
1.73
1.2
1.2
iu/l
39.3
35.5
0.31
22
146
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
30
2.68
1.72
1.1
1.2
umol/l
47.5
31.7
—
8
30
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
40
267
1.52
1.71
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
344
3085
1.18
1.70
8.9
4.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
83
1.94
1.65
1.3
2.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
855
8346
1.39
1.64
39.6
14.9
mmol/l
3.9
4.0
2.18
849
8085
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
187
0.48
1.63
1.2
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
224
1946
1.20
1.57
2.5
2.1
umol/l
3752.4
6226.4
0.45
202
1616
(3004588) Protein electrophoresis panel - Serum or Plasma
42
595
0.69
1.55
1.9
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
78
1.94
1.55
1.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
42
0.00
1.53
0.0
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
43
0.00
1.52
0.0
1.1
—
1.1
—
0
22
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
44
0.00
1.51
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
185
0.48
1.51
1.2
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
230
0.52
1.50
1.5
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
14
255
0.54
1.49
1.1
1.3
—
2.5
—
0
28
(3001019) Free T4 and TSH panel - Serum or Plasma
19
317
0.59
1.48
2.5
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
39
269
1.47
1.46
1.2
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
155
0.45
1.43
1.0
1.6
nmol/l
0.9
0.7
—
7
120
(3041096) Erythrocytes [Presence] in Urine by Automated
237
2088
1.18
1.41
9.1
3.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
137
0.43
1.41
1.0
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
16
275
0.57
1.40
1.1
1.3
—
40.0
—
0
23
(42529406) Shigella sp [Presence] in Stool by Culture
39
272
1.45
1.39
1.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
58
435
1.36
1.38
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
124
0.40
1.37
1.2
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
590
6203
0.86
1.35
3.3
4.5
mm/h
19.5
13.1
11.96
544
5712
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
15
259
0.57
1.35
1.3
1.6
—
338.1
—
0
21
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
403
0.66
1.33
1.4
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
307
0.61
1.33
1.2
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
97
1177
0.80
1.25
1.3
1.3
titre
397.9
664.5
1.62
19
289
(1002224) Polysomnography panel
14
239
0.58
1.22
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
116
1.65
1.22
1.7
2.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
6
26
2.32
1.19
2.0
1.4
e9/l
0.9
1.2
—
6
14
(3000330) Specific gravity of Urine by Test strip
64
500
1.30
1.19
5.7
3.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
284
0.63
1.16
2.5
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
20
2.51
1.15
2.2
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
20
2.51
1.15
2.2
3.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
155
0.51
1.14
1.5
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
73
587
1.26
1.10
3.7
3.6
%
0.8
0.5
0.81
29
82
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
23
337
0.67
1.07
1.7
2.0
u/l
38.4
40.3
0.14
15
294
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
263
0.64
1.03
1.4
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
75
1.74
1.03
1.4
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
202
0.59
1.02
1.1
1.2
—
5.9
—
0
19
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
68
1.77
1.01
1.2
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
76
1.72
0.99
1.4
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
18
271
0.66
0.97
2.2
1.8
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
12.2
—
0
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
30
0.00
0.97
0.0
4.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
69
1.75
0.96
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
246
0.64
0.95
1.4
1.8
g/l
1.1
1.2
0.56
16
231
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
15
93
1.62
0.94
1.3
1.8
%
90.5
89.9
0.22
15
93
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
279
0.67
0.92
1.2
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
205
1849
1.14
0.90
6.3
4.7
kg/l
1.0
1.0
0.51
22
287
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
182
0.60
0.90
1.7
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
63
512
1.25
0.90
11.3
2.7
e9/l
4.2
4.0
0.11
57
361
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
152
1.46
0.88
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
56
1.79
0.88
3.7
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
299
1.32
0.87
2.1
1.6
g/l
1.9
1.6
0.79
34
263
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
338
3151
1.12
0.86
3.2
3.7
ng/l
52.2
63.6
0.13
251
2217
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
86
729
1.20
0.83
1.9
2.9
ng/l
161.8
175.7
0.21
81
662
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
169
1880
0.88
0.83
1.6
1.7
pmol/l
54676773.6
29559373.1
0.18
139
1519
(3021960) Folate [Moles/volume] in Serum or Plasma
227
2075
1.13
0.81
1.6
1.5
nmol/l
20.3
22.5
1.59
210
1721
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
137.6
—
0
16
(46235355) HIV 1 and 2 tests - Meaningful Use set
79
670
1.20
0.77
1.2
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(44806420)
0
28
0.00
0.76
0.0
2.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
53
1.70
0.75
1.3
2.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
91
1.55
0.75
1.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
106
0.56
0.73
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
7
39
1.80
0.72
1.3
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
41
1.71
0.70
1.3
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
137
1227
1.14
0.69
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
77
1.57
0.68
2.9
3.7
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
27
1.86
0.68
1.4
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
28
362
0.77
0.67
1.0
1.1
—
266.3
—
0
15
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
179
1.35
0.67
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
70
598
1.18
0.65
3.3
3.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
30
1.67
0.61
2.2
2.1
u/l
241.4
202.0
—
5
30
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
22
0.00
0.59
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
26
332
0.78
0.59
1.0
1.6
—
8.5
—
0
8
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
64
1.57
0.58
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
7
112
0.62
0.58
1.0
1.3
—
77.8
—
0
8
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
5
86
0.58
0.56
1.2
1.1
—
69.6
—
0
7
(3038026) Centromere Ab [Units/volume] in Serum
5
87
0.57
0.56
1.2
1.1
—
88.8
—
0
5
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
107
1.41
0.55
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
69
789
0.86
0.54
1.5
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.4
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
31
251
1.24
0.51
1.8
2.1
ug/l
113.9
1225.3
0.78
31
233
(3051593) INR in Capillary blood by Coagulation assay
7
45
1.56
0.49
23.3
8.9
—
—
—
0
0
(4034850)
22
276
0.79
0.46
10.2
9.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
850
8417
1.15
0.45
25.2
9.5
u/l
21.9
22.8
1.34
841
8011
(3032773) Endomysium IgG Ab [Titer] in Serum
10
69
1.45
0.44
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
57
649
0.87
0.44
1.7
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
429
4143
1.07
0.43
2.4
2.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
78
1.42
0.43
1.2
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
62
700
0.88
0.43
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
91
0.66
0.42
1.5
1.2
—
—
—
0
0
(4306422)
12
87
1.38
0.42
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(4010399)
56
635
0.87
0.41
1.2
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
33
1.52
0.41
1.4
1.8
ml
1818.0
1868.5
—
5
26
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
16
0.00
0.41
0.0
6.5
—
—
—
0
0
(4027681)
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
82.4
—
0
18
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
35
1.43
0.39
1.6
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
35
1.43
0.39
1.0
1.4
nmol/l
133.4
133.7
—
5
35
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
80
1.38
0.38
1.8
1.8
pg
32.6
32.3
0.08
11
80
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
36
1.39
0.38
1.2
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
202
0.79
0.37
1.8
1.6
e6/l
24197.4
11727.5
1.01
11
143
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
660
0.89
0.37
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
42
1.43
0.35
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
814
8057
1.10
0.35
26.5
12.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
107
1155
0.92
0.35
10.5
6.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
132
0.75
0.32
1.1
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
46
408
1.13
0.32
3.1
3.3
ph
7.4
7.4
—
10
52
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
137
1.25
0.32
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
390
1.13
0.31
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
97
0.72
0.31
1.3
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
54
1.30
0.30
1.0
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
241
1.17
0.29
1.4
1.4
ug/g
247.4
302.6
1.35
20
133
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
107
0.75
0.29
1.4
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
57
1.23
0.29
2.0
2.3
—
—
—
0
0
(4024509)
8
110
0.72
0.29
2.6
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
94
1.28
0.28
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
66
1.21
0.26
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
66
1.21
0.26
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
66
1.21
0.26
1.3
1.2
—
—
—
0
0
(4062490)
5
71
0.70
0.26
1.4
1.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
73
0.68
0.26
1.0
1.0
ng/l
471.6
373.1
—
5
50
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
74
0.67
0.26
1.0
1.0
ng/l
60.8
55.4
—
5
51
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
5
74
0.67
0.26
1.0
1.0
ng/l
683.6
712.8
—
5
49
(3003327) Ova and parasites identified in Stool by Light microscopy
21
245
0.85
0.25
1.4
1.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
18
152
1.19
0.24
1.2
1.2
nmol/l
—
0.4
—
0
7
(3021788) Differential panel - Synovial fluid
13
158
0.82
0.23
1.8
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.4
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
39
1.28
0.23
1.0
1.2
u/l
13.2
16.3
—
5
33
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
325
0.89
0.21
1.6
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
7.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
16
188
0.85
0.21
1.0
1.2
mmol/l
3.7
3.9
0.69
16
177
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
12
0.00
0.21
0.0
4.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
712
1.07
0.21
2.3
2.4
ug/l
3.8
6.0
1.25
64
615
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
145
1.18
0.20
1.4
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(4133840)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44813793)
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
27
241
1.12
0.19
2.2
1.8
iu/l
6.5
5.3
0.34
14
71
(3022313) Gas panel - Capillary blood
27
301
0.89
0.19
4.1
3.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
55
512
1.08
0.18
2.6
2.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
43
397
1.09
0.17
3.3
3.2
mmol/l
1.9
2.2
0.24
33
294
(3025577) Chromium [Mass/volume] in Blood
7
61
1.15
0.17
2.6
2.2
ug/l
3.1
2.2
—
7
52
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
(4268621)
7
62
1.13
0.17
2.0
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
101
1.19
0.16
1.8
1.5
—
—
—
0
0
(4094501)
20
225
0.89
0.16
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
92
1.20
0.16
1.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
15
130
1.16
0.15
1.3
1.3
mu/l
228.9
49.1
0.46
15
119
(3022145) Colonoscopy Study observation
90
861
1.05
0.14
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
181
1861
0.97
0.14
1.1
1.3
u/ml
1.3
1.9
0.29
45
459
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
326
0.92
0.14
1.6
1.4
g/l
8.6
10.3
1.82
25
269
(3026361) Erythrocytes [#/volume] in Blood
861
8640
0.94
0.14
52.9
18.8
e12/l
4.0
4.4
74.92
830
8296
(3010813) Leukocytes [#/volume] in Blood
861
8640
0.94
0.14
52.9
18.8
e9/l
6.5
6.5
0.06
833
8297
(3007164) IgA [Mass/volume] in Serum or Plasma
157
1524
1.04
0.14
1.5
1.3
g/l
2.0
2.4
2.38
77
811
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
132
1.14
0.13
1.2
1.3
nmol/l
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
107
0.84
0.13
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
108
0.83
0.13
1.3
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
861
8637
0.94
0.12
52.9
18.7
e9/l
272.2
260.8
3.99
836
8332
(40760888) Immunoglobulin light chains.free panel - Serum
15
168
0.89
0.11
2.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
95
1.16
0.11
1.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
17
153
1.11
0.11
1.2
1.2
nmol/l
0.6
0.7
0.21
17
148
(3034770) Mitochondria Ab [Titer] in Serum
22
202
1.09
0.10
1.1
1.2
—
1342.0
—
0
10
(3044941) Cell count panel - Synovial fluid
15
135
1.11
0.09
1.6
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.4
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
26
242
1.08
0.09
1.8
1.5
mg/l
25.8
37.4
2.84
21
202
(3005719) IgG [Mass/volume] in Serum or Plasma
48
503
0.95
0.09
2.4
2.4
g/l
9.2
10.5
1.53
42
461
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
47
1.06
0.09
1.0
1.0
mg/l
399.8
224.3
—
5
41
(3036481) Cortisol [Moles/volume] in Serum or Plasma
77
744
1.04
0.09
3.9
1.8
nmol/l
423.6
361.9
1.68
71
664
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
54
1.11
0.09
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
62
0.81
0.08
1.4
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
7
64
1.09
0.08
2.6
2.1
ug/l
6.5
3.0
—
7
56
(3000093) Morphology [Interpretation] in Blood Narrative
7
64
1.09
0.08
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
67
1.05
0.08
1.1
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
6
74
0.81
0.07
1.0
1.2
u/l
56.5
59.3
—
6
52
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
107
1094
0.98
0.07
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
91
0.88
0.06
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
22
234
0.94
0.06
1.2
1.5
iu/ml
0.0
0.1
—
9
41
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
100
0.90
0.06
2.3
1.6
mu/l
353.7
333.4
—
9
89
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
102
0.88
0.06
1.1
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
102
0.88
0.06
1.3
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
103
0.87
0.06
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
104
0.86
0.06
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
121
0.91
0.06
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
120
0.92
0.05
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
343
0.96
0.05
1.6
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
343
0.96
0.05
1.6
1.4
g/l
3.8
3.8
0.01
26
241
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
343
0.96
0.05
1.6
1.4
g/l
7.7
7.6
0.14
26
252
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
67
655
1.02
0.04
3.3
2.7
mmol/l
1.2
1.2
0.13
60
545
(1761482) Bacteria [#/volume] in Urine by Culture
23
241
0.95
0.04
5.4
4.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
160
1.06
0.04
1.1
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
99
976
1.02
0.03
1.5
2.0
ug/g
111.3
135.4
0.32
80
748
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
45
439
1.03
0.03
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
108
0.93
0.03
2.2
2.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
25
242
1.03
0.02
1.9
1.5
mg/l
20.2
54.1
0.87
20
200
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
322
1.03
0.02
1.6
1.4
g/l
3.5
3.0
1.05
26
250
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
20
207
0.97
0.01
1.1
1.2
mg/l
554.2
470.5
0.35
20
195
(3000494) Fungus identified in Specimen by Culture
89
897
0.99
0.01
1.5
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
116
0.95
0.00
1.1
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
166
0.96
0.00
1.6
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
326
3253
1.00
0.00
2.4
2.7
ug/l
204.7
97.0
10.00
306
2948
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
26
256
1.02
0.00
1.5
1.4
g/l
0.0
0.0
0.50
26
235
(3023419) Bacteria identified in Sputum by Culture
10
98
1.02
0.00
1.9
2.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
34
338
1.01
0.00
1.1
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
157
1.02
0.00
1.4
2.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
20
197
1.02
0.00
1.1
1.7
—
26.9
—
0
7
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
24
235
1.02
0.00
1.5
1.4
g/l
0.0
0.0
0.00
24
219
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
90
1.00
0.00
1.1
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
74
0.95
0.00
1.1
1.3
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
24
240
1.00
0.00
1.5
1.4
g/l
0.0
0.0
0.00
24
220
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
7.3
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
66.0
—
0
5
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
21.0
—
0
5
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
76
0.92
0.00
1.1
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
49.1
—
0
6
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.2
—
0
5
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
77
0.91
0.00
1.0
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
89
0.90
0.00
1.3
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
5
0.00
0.00
0.0
1.6
—
13.2
—
0
5
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
17.4
—
0
8
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
38.7
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
49
1.02
0.00
10.0
2.4
%
13.4
13.4
—
5
49
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_FEMALE_GENITAL_NAS_EXALLC – Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).